Immunization News and Research RSS Feed - Immunization News and Research

NIAID partners with Liberian government to test ZMapp drug for Ebola virus disease

NIAID partners with Liberian government to test ZMapp drug for Ebola virus disease

In partnership with the Liberian government, the National Institute of Allergy and Infectious Diseases today launched a clinical trial to obtain safety and efficacy data on the investigational drug ZMapp as a treatment for Ebola virus disease. The study, which will be conducted in Liberia and the United States, is a randomized controlled trial enrolling adults and children with known Ebola virus infection. [More]
Study reveals causes of community-acquired pneumonia in children

Study reveals causes of community-acquired pneumonia in children

With the chill of winter comes a spike in community-acquired pneumonia (CAP), which spreads more easily as people retreat indoors and come into close contact. The lung infection triggers persistent coughing, chest pain, fever, and difficulty breathing, and is particularly hard on the very young and the very old. In fact, pneumonia is the leading cause of hospitalization among U.S. children, with estimated medical costs of $1 billion annually. [More]
Study points respiratory viruses as the most common cause of childhood pneumonia

Study points respiratory viruses as the most common cause of childhood pneumonia

Respiratory viruses, not bacterial infections, are the most commonly detected causes of community-acquired pneumonia in children, according to new research released Feb. 26 in the New England Journal of Medicine. [More]
Researchers examine individuals' confidence or reluctance in vaccination decision-making

Researchers examine individuals' confidence or reluctance in vaccination decision-making

Researchers explore individuals' confidence or reluctance to vaccinate their families and the associated effects on global health, in a collection published on February 25, 2015 by the open-access journal, PLOS Currents: Outbreaks. The collection is accompanied by the editorial "Hesitancy, trust and individualism in vaccination decision-making" by Jonathan E. Suk et al. from the European Centre for Disease Prevention and Control. [More]
Gates Foundation awards $2.5 million to support development of vaccine-filled microneedles

Gates Foundation awards $2.5 million to support development of vaccine-filled microneedles

The Georgia Institute of Technology and Micron Biomedical have been awarded $2.5 million in grants from the Bill & Melinda Gates Foundation to advance the development of dissolvable microneedle patches for polio immunization. The patches will be studied to evaluate their potential role as part of the worldwide efforts to eradicate polio. [More]
International phase 2/3 trial shows Gardasil 9 vaccine protects against nine HPV types

International phase 2/3 trial shows Gardasil 9 vaccine protects against nine HPV types

Approximately 12,000 women are diagnosed with cervical cancer each year in the United States and another 4,000 die annually from the disease. However, most cervical cancers are preventable through immunization against the human papillomavirus (HPV). A pivotal international phase 2/3 clinical trial involving Moffitt Cancer Center faculty demonstrated that vaccination with Gardasil 9 protects against nine HPV types, seven of which cause most cases of cervical, vulvar, and vaginal disease. [More]
PIDS statement on ongoing measles outbreak

PIDS statement on ongoing measles outbreak

The Pediatric Infectious Diseases Society, an organization of physicians, scientists, and other medical professionals dedicated to treating and preventing infectious diseases, issued a statement on Feb. 5 about the ongoing measles outbreak, urging vaccination to halt the spread of the disease and to prevent future outbreaks. [More]
Davita Kidney Care exceeds its own previous immunization rates for dialysis patients, teammates

Davita Kidney Care exceeds its own previous immunization rates for dialysis patients, teammates

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that the company is a leader in immunizations for kidney care providers and has exceeded its own previous immunization rates for both dialysis patients and teammates. [More]
Antibodies used in research lab should be made by recombinant DNA technology, say authors

Antibodies used in research lab should be made by recombinant DNA technology, say authors

Antibodies are now established as therapeutics and indispensable in the research lab. In con-trast to high-quality therapeutics, commercial antibodies used in research often do not proper-ly function, as an international group of authors around Andreas Plückthun of UZH have warned. [More]
Winners of Verizon Powerful Answers Award bring solutions to redefine the world

Winners of Verizon Powerful Answers Award bring solutions to redefine the world

Four great ideas were named first place winners of the Verizon Powerful Answers Award, a year-long global challenge to discover and help bring to market technology-based solutions with the potential to change our world. [More]
New Johns Hopkins research suggests that vitamin A may protect children against malaria

New Johns Hopkins research suggests that vitamin A may protect children against malaria

Children under age 5 living in sub-Saharan Africa were 54 percent less likely to develop malaria if they had been given a single large dose of vitamin A, new research led by the Johns Hopkins Bloomberg School of Public Health suggests. [More]
Immunization can prevent measles

Immunization can prevent measles

The recent measles outbreak linked to Disney amusement parks in southern California should not be a concern for anyone who has had measles in the past or who has received two doses of the measles vaccine. [More]
UAB doctor says measles can be halted with safe, effective measles vaccine

UAB doctor says measles can be halted with safe, effective measles vaccine

An ongoing, multistate measles outbreak linked to a California amusement park has already caused 68 confirmed cases between Jan. 1 and 23, according to the Centers for Disease Control and Prevention. [More]
Immunotherapy expert discusses the concept of precision immunology and personalized medicine

Immunotherapy expert discusses the concept of precision immunology and personalized medicine

With President Obama's recent State of the Union speech addressing the launch of a national precision medicine initiative to further tackle cancer and other diseases, a leading immunotherapy expert from Rutgers Cancer Institute of New Jersey weighs in on where we stand with precision immunology and personalized medicine and what needs to be accomplished. [More]
Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

Immunomic Therapeutics, Inc. ("Immunomic Therapeutics"), a company developing next-generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. ("Astellas") today announced they have entered into an exclusive license agreement for Japan to develop and commercialize JRC2-LAMP-vax, Immunomic Therapeutics' vaccine designed to treat allergies induced by Japanese red cedar pollen. [More]
UTMB study reveals that only about half of teenage girls get HPV vaccine at the recommended age

UTMB study reveals that only about half of teenage girls get HPV vaccine at the recommended age

It's a virus that is responsible for almost all cases of cervical cancer but a new study by University of Texas Medical Branch at Galveston researchers indicates that only about half of the girls receive the vaccine at the recommended age to best protect themselves. [More]
Study on influenza B viruses could help make flu vaccination programs more effective

Study on influenza B viruses could help make flu vaccination programs more effective

An analysis of 10 years' worth of data on human influenza B viruses has shed new light on the pathogen which can cause the seasonal flu. Findings from this study could help make flu immunization programs more effective; by better targeting vaccines or by eventually eliminating one of the flu lineages completely. [More]
Effective vaccine booster schedules needed to fight against whooping cough resurgence

Effective vaccine booster schedules needed to fight against whooping cough resurgence

A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist. [More]
Researchers identify clusters of underimmunization, vaccine refusal in Northern California

Researchers identify clusters of underimmunization, vaccine refusal in Northern California

Researchers used spatial analysis software and electronic medical records to identify clusters of underimmunization and vaccine refusal among Kaiser Permanente members in Northern California, according to a study published today in the journal Pediatrics. [More]
Everyday actions could help prevent spread of flu among college students

Everyday actions could help prevent spread of flu among college students

As local college students return to Philadelphia from their long winter breaks over the next several days, it is likely that they'll be bringing who-knows-what germs with them from home, said Stacey A. Gorski, PhD, a biology professor who specializes in immunology at University of the Sciences in Philadelphia. [More]